Columbus City Attorney Zach Klein announced that the city has filed a lawsuit against several drug companies and pharmacy ...

This month on pharmaphorum, we explore the history of French pharmaceutical company Sanofi, which was created through many partnerships and acquisitions over a period of 100 years. Sanofi is one ...

Sanofi India Limited ... for the treatment of hyperglycemia in people with type 1 or type 2 diabetes.On 13 December 2010, Aventis Pharma Ltd announced that it has agreed with its joint venture ...

The backdrop: People with diabetes have difficulty maintaining ... Novo Nordisk and Sanofi-Aventis of working with PBMs like CVS Caremark, Express Scripts and Optum Rx. The manufacturers and ...

However, this is increasingly being shadowed by a growing incidence of lifestyle-related diseases such as hypertension, diabetes and ... Remaining MNCs include Sanofi Aventis (#13th Rank ...

Clarius Group LLC lifted its holdings in shares of Sanofi (NASDAQ:SNY – Free Report) by 11.9% in the fourth quarter, ...

After hitting a regulatory roadblock in 2022, Sanofi’s consumer healthcare business Opella has secured the FDA’s blessing to ...

Sanofi’s Dupixent and new drugs drive growth, despite near-term pressures. See why SFY stock’s product pipeline makes it a ...

Kennedy Jr. to run the Department of Health and Human Services. How do Sanofi CEO Paul Hudson and GSK CEO Emma Walmsley—who lead two of the top vaccine companies in the world—feel about the ...

Sanofi is handing SK bioscience 50 million euros ($52 million) as the longtime partners take their next-gen pneumococcal conjugate vaccine program into phase 3. The move follows a phase 2 win last ...

Frexalimab is under clinical development by Sanofi and currently in Phase II for Type 1 Diabetes (Juvenile Diabetes). According to GlobalData, Phase II drugs for Type 1 Diabetes (Juvenile Diabetes) ...

A new study has considered some of the potential benefits and risks of glucagon-like peptide 1 receptor agonists (GLP-1RAs), ...